ID

12156

Beskrivning

An open-label, multicenter, randomized, comparative, phase III study to evaluate the efficacy and safety of rituximab plus fludarabine and cyclophosphamide (FCR) versus fludarabine and cyclophosphamide alone (FC) in previously treated patients with CD20 positive B-cell chronic lymphocytic leukemia (CLL). FCR Versus FC Alone in the Treatment of Chronic Lymphocytic Leukemia (CLL) in Relapsed Patients NCT00090051 Roche BO17072

Nyckelord

  1. 2015-10-01 2015-10-01 -
  2. 2015-10-28 2015-10-28 -
  3. 2015-10-28 2015-10-28 -
Uppladdad den

1 oktober 2015

DOI

För en begäran logga in.

Licens

Creative Commons BY-NC 3.0 Legacy

Modellkommentarer :

Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.

Itemgroup-kommentar för :

Item-kommentar för :

Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.

CLL Pharmacokinetics NCT00090051 BO17072

Pharmacokinetics Cycle 1 and 3 of Chronic lymphocytic leukemia NCT0090051

Blood sampling for pharmacokinetics (Rituximab)
Beskrivning

Blood sampling for pharmacokinetics (Rituximab)

Scheduled sampling time
Beskrivning

Scheduled sampling time

Datatyp

time

Måttenheter
  • hh
hh
Scheduled sampling time
Beskrivning

Scheduled sampling time

Datatyp

date

Sample number
Beskrivning

Sample number

Datatyp

integer

Sample collection date
Beskrivning

Sample collection date

Datatyp

date

Måttenheter
  • dd/mm/yy
dd/mm/yy
Sample collection time
Beskrivning

Sample collection time

Datatyp

time

Måttenheter
  • hh:mm
hh:mm
Remarks
Beskrivning

Remarks

Datatyp

text

Alias
UMLS CUI [1]
C0947611
If patient takes Rituximab on day 1, then start of Fludarabine and Cyclophosphamide pharmacokinetic sampling starts on day 2, immediately prior the infusion.
Beskrivning

If patient takes Rituximab on day 1, then start of Fludarabine and Cyclophosphamide pharmacokinetic sampling starts on day 2, immediately prior the infusion.

Scheduled sampling time
Beskrivning

After the end of infusion

Datatyp

time

Måttenheter
  • h
h
Sampling number
Beskrivning

Sampling number

Datatyp

integer

Sample collection date
Beskrivning

Sample collection date

Datatyp

date

Måttenheter
  • dd/mm/yy
dd/mm/yy
Sample collection time
Beskrivning

Sample collection time

Datatyp

time

Måttenheter
  • hh:mm
hh:mm
Remarks
Beskrivning

Remarks

Datatyp

text

Alias
UMLS CUI [1]
C0947611

Similar models

Pharmacokinetics Cycle 1 and 3 of Chronic lymphocytic leukemia NCT0090051

Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Item Group
Blood sampling for pharmacokinetics (Rituximab)
Scheduled sampling time
Item
Scheduled sampling time
time
Scheduled sampling time
Item
Scheduled sampling time
date
Sample number
Item
Sample number
integer
Sample collection date
Item
Sample collection date
date
Sample collection time
Item
Sample collection time
time
Remarks
Item
Remarks
text
C0947611 (UMLS CUI [1])
Item Group
If patient takes Rituximab on day 1, then start of Fludarabine and Cyclophosphamide pharmacokinetic sampling starts on day 2, immediately prior the infusion.
Scheduled sampling time
Item
Scheduled sampling time
time
Sampling number
Item
Sampling number
integer
Sample collection date
Item
Sample collection date
date
Sample collection time
Item
Sample collection time
time
Remarks
Item
Remarks
text
C0947611 (UMLS CUI [1])

Använd detta formulär för feedback, frågor och förslag på förbättringar.

Fält markerade med * är obligatoriska.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial